Optimer Pharmaceuticals
A biopharmaceutical company focused on discovering, developing and commercializing.
Launch date
Employees
Market cap
€265.6b
Enterprise valuation
€289.6b (Public information from Sep 2024)
Share price
$117.23 MRK
San Diego California (HQ)
Authorizing premium user...